Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Health Catalyst (HCAT) Interest Expenses (2018 - 2023)

Health Catalyst filings provide 6 years of Interest Expenses readings, the most recent being -$2.6 million for Q4 2023.

  • On a quarterly basis, Interest Expenses fell 155.97% to -$2.6 million in Q4 2023 year-over-year; TTM through Sep 2024 was -$2.6 million, a 65.18% increase, with the full-year FY2023 number at -$9.1 million, down 642.67% from a year prior.
  • Interest Expenses hit -$2.6 million in Q4 2023 for Health Catalyst, roughly flat from -$2.6 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4.4 million in Q3 2021 to a low of -$2.6 million in Q4 2023.
  • Median Interest Expenses over the past 5 years was $1.1 million (2019), compared with a mean of $1.2 million.
  • Biggest five-year swings in Interest Expenses: soared 722.63% in 2020 and later crashed 1735.92% in 2023.
  • Health Catalyst's Interest Expenses stood at $495000.0 in 2019, then soared by 722.63% to $4.1 million in 2020, then grew by 7.47% to $4.4 million in 2021, then tumbled by 123.35% to -$1.0 million in 2022, then plummeted by 155.97% to -$2.6 million in 2023.
  • The last three reported values for Interest Expenses were -$2.6 million (Q4 2023), -$2.6 million (Q3 2023), and -$2.1 million (Q2 2023) per Business Quant data.